Shanghai Institute of Biological Products Co., Ltd., the full name of which is Shanghai Institute of Biological Products Co., Ltd., referred to as "China Bio-Shanghai Company", was established in 1993 and is located in Shanghai. It is an enterprise mainly engaged in science and technology promotion and application services. The executive director and general manager is Li Xiuling.
The business scope of Shanghai Institute of Biological Products Co., Ltd. is to produce and sell blood products, vaccines, bioengineering products and medical experimental animals. Engaged in the import and export business of goods and technologies.
The development project of Fengxian Biomedical Industrialization Base is located in Fengxian Biomedical Base (480 mu) (hereinafter referred to as Fengxian Production Base) in Nanqiao Xincheng Economic Development Zone, Fengxian, Shanghai. Shanghai Fengxian production base has built a new biological vaccine and blood production base for intradermal injection of BCG, long-acting gene interferon, live attenuated varicella vaccine, series attenuated measles-mumps-rubella vaccine, rabies vaccine, influenza vaccine and blood products.
The workshop of logistics center is a unit project of the first phase development project of Fengxian biomedical industrialization base of Shanghai Institute of Biological Products. The workshop is close to the logistics entrance of the factory and close to the road in the east, which is the logistics hub of the whole factory. The logistics center consists of raw and auxiliary materials at room temperature and finished product cold storage.